The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
that will be good i will top up again then and with brexit teapots this will be a good buy :-) profit
this time sub 90p on cards
not yet for me
Spire Healthcare Group (SPI) Price Target Lowered to GBX 115 at Barclays
Posted by Steven Smith on Apr 16th, 2019 // Comments off
Spire Healthcare Group PLC logoSpire Healthcare Group (LON:SPI) had its price target cut by Barclays from GBX 130 ($1.70) to GBX 115 ($1.50) in a research report sent to investors on Friday morning, ThisIsMoney.Co.Uk reports. They currently have an underweight rating on the stock
I reckon
anybody expecting any? 1 code late on?
The shorters appear to have the share price back in the pre-results range, where they can continue to play their little games as the recent renewed interest in this share wanes. It would not surprise me to see the share price drift down to 128 or lower by the end of the day, and I expect a trading range of 127-133, apart from when the shorters decide to come out to play. I may sound a little cynical, but I am disappointed that there doesn’t appear to be any consolidation on the upward movement that we saw on Monday and Tuesday. My opinion - DYOR etc - my pessimism has been proven wrong in the past and I would be happy if that were the case here.
GreenWolf. No problem with that.The AIM share concerned is IQE; although I had more success with the link on the advfn board than with the LSE link. Thanks again, and best wishes with your investment here and elsewhere.
TLW - all the best with that - there is next to no interest in the, alleged, shenanigans going on in the AIM market and I agree that it worse than it has ever been. There is one thing doing your research, technical etc etc and investing your money but when the deck is stacked, yes, it can truly hurt. I was in New World Oil and Gas when that all kicked off and, excepting a fine for their broker, it all got brushed under the carpet. That was an interesting case of a broker forward selling stock that needed shareholder approval at an EGM. The cat got out of the bag and shareholders rejected the issue of the placing shares and a naked short developed. Technically the broker had nowhere to hide and the market started to react - the price rose big time. But strangely enough, the share got suspended and an Open Offer saved the broker and of course left lots of PIs who had bought in on the rises losing bucket loads of money in the process. I'm interested in which AIM share you are on about, but understand if you don't want to post it on here. Good luck and hope Spire makes you a fair bit at some point.
Thanks GreenWolf. You have offered a plausible explanation of the current situation. Agreed that the fundamentals are sound, and the recent statement offered much to calm the market. It would appear that the short-term sellers are not done here yet. I hope that a bid materialises and catches them out for their sins.
Short-term selling in the UK is putting a lot of people off investing; recently we had a decent well-informed investor on this board who threw in the towel because he was totally disenchanted with the nature of UK markets. Earlier today on another board, I signed a petition protesting about short-term selling in the AIM market. This will be forwarded to the UK Parliament once they have 10,000 signatures. Regards.
TLW - IMHO it's the battle of the shorts and the bulls. The FCA open positions show an increase in overall short positions in Spire over the past month including a new position from Blackrock - not insignificant at 0.5%. Big players like Blackrock etc won't want to get too burnt on any open short. The fundamentals in Spire are still good - you know I have said that before - but there are plenty of things (open shorts) working against us. And of course that elusive takeover bid that we all talk about occasionally on here could come at ay time, although I suspect our Brexit position has a decent bearing on things. I personally don't expect any bid until we know exactly what is happening on the Brexit front . GLA
I am at a loss to understand what is going on with the Spire Healthcare share price this week? Yesterday we witnessed a rise to super-140p followed by an abrupt decline. Today, following a sub 130-start, the share price quickly rose to 140 and was then subjected to a rapid decline to below yesterday’s closing value - and the decline looks set to continue. There are weird “games” afoot and I cannot comprehend the extreme volatility that the SPI share price is currently experiencing? Any clarification would be gratefully accepted.
.... to see the abrupt drop downward following the unexpected rise this morning although the share price is currently at the level that I expected it to be today. I remember the SPI share price doing something similar when I was previously invrested - a sudden when it was least expected followed by an abrupt fall to lower than its starting level. I regretted not selling for a profit on the previous occasion, and have similar regrets today.
Spire now has a strong and experienced executive team in place and we are looking forward to 2019 and beyond.
We are taking a measured approach to 2019, which will be a year of consolidation. We expect modest revenue growth, and will see the full year effect of investments coming through, whilst we will continue to achieve further efficiencies. We are focused on cash generation and debt reduction, placing Spire in a strong position for future EBITDA growth.
Our strategy is absolutely the right one for Spire so that we continue to be well positioned to reinforce our leading role in the independent sector and UK healthcare sector as a whole."
It looks like 134.7p UT. I was not expecting this after yesterday's announcement, and had a vision of a slow and steady rise breaking into the 130s during the next month or so. Is this sustainable? Inevitably, there will be some pullback next week.
Indeed it will
it will be interesting to see the UT later don't you think?
Stampede of buys going through.
Agreed. Actually somewhat surprised to see the sp rising again this morning, but I guess all of the bad news has been 'priced in' already.
There was a second RNS today, namely that Peter Bamford, Spire's Deputy Chairman has stood down. I note that his shareholding in the company amounted to 5000 shares. There is no rule which states that directors should hold a resonable shareholding in the company they represent, and I have noted that many senior directors in various companies, like Mr. Bamford, choose not to do so. However when directors carry more substantial shareholdings than this, it does boost investor confidence. It is one of the (minor) checks that I always make before choosing to invest in a company.
The RNS was more or less as expected. The business appears to be focusing on the quality and structure of its operations with a view to future growth. The good standard of CCQ across the group will add value in the event of a future takeover bid. The lower profit was already expected, and it would appear that the share price has now stabilised at the current level.
The share price has fallen to the lower end of its trading range today. It could well be the case that the market will give the share price another mauling tomorrow, as has been the case recently. There wasn't any new information on the previous occasion, but the price dropped considerably.
I am holding as I believe that sooner or later there may well be another takeover bid on the table, especially at the current market valuation. I would expect a bid price of 220p+ in the event that one is put forward.
Should be an interesting last few hours today I reckon
So am I. The current issue as far as I am concerned is whether the share price will suffer yet another abrupt decline on Thursday, as has been the case recently although all successive share price reductions appear to have been based on the same information.
Nevertheless, my plan is to hold - at least until this business reaches a value commensurate with its potential. A takeover bid at this point in time could have a very positive effect as the business is currently valued at well below its NAV.
When I read the recent Credit Suisse appraisal, I was surprised to find that they had arbitrarily cut the value of Spire Healthcare's assets by 50% - based on reduced earnings, and quoted 85p as their target price.
it is up 30% since the lows , i am quite happy with that for now.